Clinical Trial Update: MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update examining MRI-detected blood vessel changes in patients with stage III or IV renal cell carcinoma treated with bevacizumab alone or with in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Roferon-A (interferon alfa-2a)

Snippet

Sponsor: Mount Vernon Cancer Centre at Mount Vernon Hospital | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN